{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:47:12Z","timestamp":1791499632076,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chi-Mei\/ National Cheng Kung University","award":["CMNCKU11207"],"award-info":[{"award-number":["CMNCKU11207"]}]},{"name":"National Science and Technology Council","award":["NSTC 114-2314-B-384-001"],"award-info":[{"award-number":["NSTC 114-2314-B-384-001"]}]},{"name":"National Science and Technology Council","award":["NSTC 114-2320-B-075B-002"],"award-info":[{"award-number":["NSTC 114-2320-B-075B-002"]}]},{"name":"National Science and Technology Council","award":["NSTC 111-2314-B-309-001, and NSTC 113-2320-B-037-025"],"award-info":[{"award-number":["NSTC 111-2314-B-309-001, and NSTC 113-2320-B-037-025"]}]},{"name":"National Science and Technology Council","award":["NSTC 111-2628-B-006-010-MY3"],"award-info":[{"award-number":["NSTC 111-2628-B-006-010-MY3"]}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"crossref","award":["KMU-Q113010, 113CM-KMU-10, KMU-TC113A04, and KMU-Q114011"],"award-info":[{"award-number":["KMU-Q113010, 113CM-KMU-10, KMU-TC113A04, and KMU-Q114011"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Muscle-invasive urothelial carcinoma (MIUC) poses higher risks of recurrence and metastasis compared with non-muscle-invasive urothelial carcinoma (NMIUC). However, difficulties in early detection and the invasive nature of current diagnostic procedures. Using next-generation sequencing (NGS), we aimed to profile comprehensive surveillance of urinary microRNAs (miRNAs) as a promising non-invasive tool for assessing urothelial carcinoma (UC) and identify differentially expressed miRNAs (DEmiRNAs) in patients with MIUC or NMIUC, providing insights into UC progression and molecular mechanisms in Taiwanese patients. We analyzed the clinical differences between patients with MIUC or NMIUC in treatment-na\u00efve patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Urinary miRNAs were profiled using NGS. DEmiRNAs were identified with DESeq2, and target prediction was performed using TarBase-v9.0 and DIANA-microT. Enrichment analysis was conducted with the miEAA tool to link DEmiRNAs to biological pathways and processes, focusing on the KEGG pathways and Gene Ontology (GO) annotations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 52 participants, significantly more patients with MIUC used herbal medicines compared with the NMIUC group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.027). A total of 1,967 DEmiRNAs were detected comprehensively, with 691 upregulated and 232 downregulated in MIUC versus NMIUC. Notably, hsa-miR-3168 exhibited the highest upregulation (10.2-fold), while hsa-miR-511-3p was the most downregulated (9.32-fold). KEGG analysis revealed that upregulated DEmiRNAs were most enriched in amino acid biosynthesis pathways, while downregulated DEmiRNAs were associated with the Hedgehog signaling pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights urinary DEmiRNAs detected via NGS as a potential non-invasive diagnostic tool. Pathway analyses of DEmiRNAs provided valuable insights into UC progression and offers opportunities for future therapeutic development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-15284-5","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T02:33:53Z","timestamp":1763778833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive surveillance of MicroRNA to discriminate between muscle-invasive and non-muscle-invasive urothelial carcinoma based on noninvasive urinary small RNA sequencing in Taiwanese patients"],"prefix":"10.1186","volume":"25","author":[{"given":"I-Ning","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-An","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Sheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jenn","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Shuo","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Hua","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"15284_CR1","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Paris. https:\/\/uroweb.org\/guidelines\/non-muscle-invasive-bladder-cancer (2024)."},{"issue":"3","key":"15284_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"15284_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41571-023-00826-2","volume":"21","author":"R Nadal","year":"2024","unstructured":"Nadal R, Valderrama BP, Bellmunt J. Progress in systemic therapy for advanced-stage urothelial carcinoma. Nat Rev Clin Oncol. 2024;21(1):8\u201327.","journal-title":"Nat Rev Clin Oncol"},{"key":"15284_CR4","unstructured":"National Institutes of Health, National Cancer Institute. Cancer stat facts: bladder cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html (2024)."},{"issue":"6","key":"15284_CR5","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s00204-022-03260-y","volume":"96","author":"HT Hsu","year":"2022","unstructured":"Hsu HT, Lee HL, Cheng HH, Chang CH, Liu CS, Hsiao PJ, et al. Relationships of multiple metals exposure, global DNA methylation, and urothelial carcinoma in central Taiwan. Arch Toxicol. 2022;96(6):1893\u2013903.","journal-title":"Arch Toxicol"},{"issue":"5","key":"15284_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20(5):287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"issue":"14","key":"15284_CR7","doi-asserted-by":"publisher","first-page":"15350","DOI":"10.1002\/cam4.6084","volume":"12","author":"YH Chang","year":"2023","unstructured":"Chang YH, Hsu WL, Lee YK, Chiang CJ, Yang YW, You SL, et al. Trends and sex-specific incidence of upper urinary tract cancer in Taiwan: a birth cohort study. Cancer Med. 2023;12(14):15350\u20137.","journal-title":"Cancer Med"},{"issue":"2","key":"15284_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/iju.14731","volume":"29","author":"MY Lin","year":"2022","unstructured":"Lin MY, Niu SW, Li WM, Lee HL, Chen LT, Wu WJ, et al. Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001\u20132010). Int J Urol. 2022;29(2):121\u20137.","journal-title":"Int J Urol"},{"issue":"6","key":"15284_CR9","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1342::AID-CNCR17>3.0.CO;2-B","volume":"85","author":"YH Chou","year":"1999","unstructured":"Chou YH, Huang CH. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer. 1999;85(6):1342\u20134.","journal-title":"Cancer"},{"issue":"1","key":"15284_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","volume":"84","author":"M Roupr\u00eat","year":"2023","unstructured":"Roupr\u00eat M, Seisen T, Birtle AJ, Capoun O, Comp\u00e9rat EM, Dominguez-Escrig JL, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol. 2023;84(1):49\u201364.","journal-title":"Eur Urol"},{"issue":"2","key":"15284_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.juro.2008.10.003","volume":"181","author":"CH Chen","year":"2009","unstructured":"Chen CH, Chiou HY, Hsueh YM, Chen CJ, Yu HJ, Pu YS. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in Taiwan. J Urol. 2009;181(2):547\u201352. discussion 53.","journal-title":"J Urol"},{"issue":"1","key":"15284_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R, Comp\u00e9rat EM, Cowan NC, Gakis G, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79(1):82\u2013104.","journal-title":"Eur Urol"},{"issue":"10","key":"15284_CR13","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.21037\/tcr-20-1990","volume":"9","author":"HH Lee","year":"2020","unstructured":"Lee HH, Kim SH. Review of non-invasive urinary biomarkers in bladder cancer. Transl Cancer Res. 2020;9(10):6554\u201364.","journal-title":"Transl Cancer Res"},{"key":"15284_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2147\/CEOR.S274951","volume":"12","author":"LJ Lee","year":"2020","unstructured":"Lee LJ, Kwon CS, Forsythe A, Mamolo CM, Masters ET, Jacobs IA. Humanistic and economic burden of non-muscle invasive bladder cancer: results of two systematic literature reviews. Clinicoecon Outcomes Res. 2020;12:693\u2013709.","journal-title":"Clinicoecon Outcomes Res"},{"issue":"1","key":"15284_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00690-x","volume":"12","author":"X Wang","year":"2024","unstructured":"Wang X, Lu Y, Zhao R, Zhu B, Liu J, Yue Q, et al. Global surveillance of circulating MicroRNA for diagnostic and prognostic assessment of acute myocardial infarction based on the plasma small RNA sequencing. Biomark Res. 2024;12(1):143.","journal-title":"Biomark Res"},{"key":"15284_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115027","volume":"165","author":"S Wu","year":"2023","unstructured":"Wu S, Li R, Jiang Y, Yu J, Zheng J, Li Z, et al. Liquid biopsy in urothelial carcinoma: detection techniques and clinical applications. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023;165: 115027.","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie."},{"issue":"3","key":"15284_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41416-021-01672-8","volume":"126","author":"S Toden","year":"2022","unstructured":"Toden S, Goel A. Non-coding RNAs as liquid biopsy biomarkers in cancer. Br J Cancer. 2022;126(3):351\u201360.","journal-title":"Br J Cancer"},{"key":"15284_CR18","doi-asserted-by":"publisher","first-page":"108123","DOI":"10.1016\/j.pharmthera.2022.108123","volume":"234","author":"H Wang","year":"2022","unstructured":"Wang H, Meng Q, Qian J, Li M, Gu C, Yang Y, Review. RNA-based diagnostic markers discovery and therapeutic targets development in cancer. Pharmacol Ther. 2022;234:108123.","journal-title":"Pharmacol Ther"},{"issue":"7","key":"15284_CR19","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","volume":"55","author":"T Kim","year":"2023","unstructured":"Kim T, Croce CM. Microrna: trends in clinical trials of cancer diagnosis and therapy strategies. Exp Mol Med. 2023;55(7):1314\u201321.","journal-title":"Exp Mol Med"},{"key":"15284_CR20","doi-asserted-by":"crossref","unstructured":"Taheri M, Shirvani-Farsani Z, Ghafouri-Fard S, Omrani MD. Expression profile of MicroRNAs in bladder cancer and their application as biomarkers. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie. 2020;131:110703.","DOI":"10.1016\/j.biopha.2020.110703"},{"issue":"1","key":"15284_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1406-6","volume":"38","author":"C Braicu","year":"2019","unstructured":"Braicu C, Buiga R, Cojocneanu R, Buse M, Raduly L, Pop LA, et al. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression. J Exp Clin Cancer Res. 2019;38(1):433.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"15284_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jmoldx.2013.05.008","volume":"15","author":"N Ratert","year":"2013","unstructured":"Ratert N, Meyer HA, Jung M, Lioudmer P, Mollenkopf HJ, Wagner I, et al. MiRNA profiling identifies candidate Mirnas for bladder cancer diagnosis and clinical outcome. J Mol Diagn. 2013;15(5):695\u2013705.","journal-title":"J Mol Diagn"},{"issue":"4","key":"15284_CR23","first-page":"265","volume":"35","author":"V Singh","year":"2024","unstructured":"Singh V, Sen A, Saini S, Dwivedi S, Agrawal R, Bansal A, et al. MicroRNA significance in cancer: an updated review on Diagnostic, Prognostic, and therapeutic perspectives. Ejifcc. 2024;35(4):265\u201384.","journal-title":"Ejifcc"},{"issue":"3","key":"15284_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels PA, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A, et al. The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol. 2020;38(3):276\u20138.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"15284_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"16","key":"15284_CR26","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA. 2003;100(16):9440\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"W1","key":"15284_CR27","doi-asserted-by":"publisher","first-page":"W148","DOI":"10.1093\/nar\/gkad283","volume":"51","author":"S Tastsoglou","year":"2023","unstructured":"Tastsoglou S, Alexiou A, Karagkouni D, Skoufos G, Zacharopoulou E, Hatzigeorgiou AG. DIANA-microT 2023: including predicted targets of virally encoded MiRNAs. Nucleic Acids Res. 2023;51(W1):W148\u201353.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"15284_CR28","doi-asserted-by":"publisher","first-page":"D304","DOI":"10.1093\/nar\/gkad1071","volume":"52","author":"G Skoufos","year":"2023","unstructured":"Skoufos G, Kakoulidis P, Tastsoglou S, Zacharopoulou E, Kotsira V, Miliotis M, et al. TarBase-v9.0 extends experimentally supported miRNA\u2013gene interactions to cell-types and virally encoded MiRNAs. Nucleic Acids Res. 2023;52(D1):D304\u201310.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"15284_CR29","doi-asserted-by":"publisher","first-page":"W521","DOI":"10.1093\/nar\/gkaa309","volume":"48","author":"F Kern","year":"2020","unstructured":"Kern F, Fehlmann T, Solomon J, Schwed L, Grammes N, Backes C, et al. MiEAA 2.0: integrating multi-species MicroRNA enrichment analysis and workflow management systems. Nucleic Acids Res. 2020;48(W1):W521\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"15284_CR30","doi-asserted-by":"publisher","first-page":"W319","DOI":"10.1093\/nar\/gkad392","volume":"51","author":"E Aparicio-Puerta","year":"2023","unstructured":"Aparicio-Puerta E, Hirsch P, Schmartz GP, Kern F, Fehlmann T, Keller A. MiEAA 2023: updates, new functional MicroRNA sets and improved enrichment visualizations. Nucleic Acids Res. 2023;51(W1):W319-25.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"15284_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neuron.2013.10.062","volume":"81","author":"RL Boudreau","year":"2014","unstructured":"Boudreau RL, Jiang P, Gilmore BL, Spengler RM, Tirabassi R, Nelson JA, et al. Transcriptome-wide discovery of MicroRNA binding sites in human brain. Neuron. 2014;81(2):294\u2013305.","journal-title":"Neuron"},{"issue":"12","key":"15284_CR32","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/s41593-018-0265-3","volume":"21","author":"TJ Nowakowski","year":"2018","unstructured":"Nowakowski TJ, Rani N, Golkaram M, Zhou HR, Alvarado B, Huch K, et al. Regulation of cell-type-specific transcriptomes by microRNA networks during human brain development. Nat Neurosci. 2018;21(12):1784\u201392.","journal-title":"Nat Neurosci"},{"issue":"9","key":"15284_CR33","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1056\/NEJMoa022148","volume":"349","author":"HB Grossman","year":"2003","unstructured":"Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349(9):859\u201366.","journal-title":"N Engl J Med"},{"issue":"3","key":"15284_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.fjurol.2024.102838","volume":"35","author":"T Palkowski","year":"2025","unstructured":"Palkowski T, Bibeau F, Thiery-Vuillemin A, Kleinclauss F, Frontczak A. High-risk non-muscle invasive bladder cancer: outcomes of patients who cannot benefit from standard of care. The French Journal of Urology. 2025;35(3):102838.","journal-title":"The French Journal of Urology"},{"issue":"4","key":"15284_CR35","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00345-022-04100-5","volume":"41","author":"KG Dickman","year":"2023","unstructured":"Dickman KG, Chen CH, Grollman AP, Pu YS. Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review. World J Urol. 2023;41(4):899\u2013907.","journal-title":"World J Urol"},{"issue":"7341","key":"15284_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature09851","volume":"472","author":"K Shin","year":"2011","unstructured":"Shin K, Lee J, Guo N, Kim J, Lim A, Qu L, et al. Hedgehog\/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature. 2011;472(7341):110\u20134.","journal-title":"Nature"},{"issue":"3","key":"15284_CR37","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s12253-018-0477-6","volume":"25","author":"T Nedjadi","year":"2019","unstructured":"Nedjadi T, Salem N, Khayyat D, Al-Sayyad A, Al-Ammari A, Al-Maghrabi J. Sonic hedgehog expression is associated with lymph node invasion in urothelial bladder cancer. Pathol Oncol Res. 2019;25(3):1067\u201373.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"15284_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.critrevonc.2013.08.008","volume":"89","author":"L Cheng","year":"2014","unstructured":"Cheng L, Davison DD, Adams J, Lopez-Beltran A, Wang L, Montironi R, et al. Biomarkers in bladder cancer: translational and clinical implications. Crit Rev Oncol Hematol. 2014;89(1):73\u2013111.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"15284_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06435-w","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Cui L, Lu S, Xu S. Amino acid metabolism in tumor biology and therapy. Cell Death Dis. 2024;15(1):42.","journal-title":"Cell Death Dis"},{"key":"15284_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","volume":"45","author":"F Massari","year":"2016","unstructured":"Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, et al. Metabolic phenotype of bladder cancer. Cancer Treat Rev. 2016;45:46\u201357.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"15284_CR41","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s12094-022-02994-6","volume":"25","author":"J Borowczak","year":"2023","unstructured":"Borowczak J, Szczerbowski K, Maniewski M, Zdrenka M, S\u0142upski P, Andrusewicz H, et al. The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma. Clin Transl Oncol. 2023;25(3):830\u201340.","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"15284_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajur.2016.09.005","volume":"3","author":"T Kobayashi","year":"2016","unstructured":"Kobayashi T. Understanding the biology of urothelial cancer metastasis. Asian J Urol. 2016;3(4):211\u201322.","journal-title":"Asian J Urol"},{"issue":"2","key":"15284_CR43","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1016\/j.clgc.2017.10.011","volume":"16","author":"ST Liu","year":"2018","unstructured":"Liu ST, Hui G, Mathis C, Chamie K, Pantuck AJ, Drakaki A. The current status and future role of the phosphoinositide 3 kinase\/AKT signaling pathway in urothelial cancer: an old pathway in the new immunotherapy era. Clin Genitourin Cancer. 2018;16(2):e269-76.","journal-title":"Clin Genitourin Cancer"},{"key":"15284_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082155","author":"H Ide","year":"2020","unstructured":"Ide H, Miyamoto H. The role of steroid hormone receptors in urothelial tumorigenesis. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12082155.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"15284_CR45","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1158\/1535-7163.MCT-17-0786","volume":"17","author":"S Inoue","year":"2018","unstructured":"Inoue S, Ide H, Mizushima T, Jiang G, Netto GJ, Gotoh M, et al. Nuclear factor-\u03baB promotes urothelial tumorigenesis and cancer progression via cooperation with androgen receptor signaling. Mol Cancer Ther. 2018;17(6):1303\u201314.","journal-title":"Mol Cancer Ther"},{"issue":"11","key":"15284_CR46","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1080\/09168451.2014.943647","volume":"78","author":"M Yamasaki","year":"2014","unstructured":"Yamasaki M, Soda S, Sakakibara Y, Suiko M, Nishiyama K. The importance of 1,2-dithiolane structure in \u03b1-lipoic acid for the downregulation of cell surface \u03b21-integrin expression of human bladder cancer cells. Biosci Biotechnol Biochem. 2014;78(11):1939\u201342.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"5","key":"15284_CR47","first-page":"5513","volume":"14","author":"S Vallo","year":"2017","unstructured":"Vallo S, Rutz J, Kautsch M, Winkelmann R, Michaelis M, Wezel F, et al. Blocking integrin \u03b21 decreases adhesion in chemoresistant urothelial cancer cell lines. Oncol Lett. 2017;14(5):5513\u20138.","journal-title":"Oncol Lett"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15284-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15284-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15284-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T20:01:51Z","timestamp":1767038511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15284-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15284"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15284-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the institutional and national research committees, and the 1964 Helsinki Declaration and its later amendments. The study protocol was approved by the Institutional Review Board of Chi Mei Medical Center, Taiwan (approval number: 10612-015). Informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1900"}}